Provista and Coral Join Forces to Enhance Pharmacy Cost Management Efficiency

Partnership for Cost Optimization



In a significant development for independent infusion centers, Provista, a subsidiary of Vizient, has forged a strategic alliance with Coral. This initiative aims to optimize pharmacy costs and infusion services through robust technology and strategic procurement practices. With Vizient's formidable presence in the healthcare purchasing landscape, the collaboration seeks to leverage its extensive contract catalog to bolster savings on pharmaceutical acquisitions.

Enhancing Access to Affordable Therapies



The partnership addresses the pressing need for community providers to not only secure contracts but also to gain comprehensive support in procurement, administration, and reimbursement processes. According to Jeremy Moskow, president of Coral, this collaboration empowers infusion providers by granting them the purchasing power and resources necessary to thrive in a competitive marketplace. The goal is to maintain access to critical therapies in community settings while ensuring affordability and sustainability.

A Shift in Infusion Service Dynamics



The healthcare environment often presents challenges, particularly for independent infusion centers that struggle with direct contracting and managing multiple distributor connections. Provista’s established success in supporting these providers allows for a transformation in how they engage with procurement strategies. Coral aims to reshape this paradigm, providing a more aligned and efficient model that enhances overall operational effectiveness. Micah Smith, senior vice president of strategic sales at Vizient, emphasized the importance of such a structure in streamlining the infusion service ecosystem.

About the Partners



Vizient, Inc.


Vizient is recognized as the largest provider-driven healthcare performance improvement firm in the United States, servicing over 65% of acute care providers and 97% of academic medical centers. With a substantial annual purchasing volume exceeding $140 billion, Vizient is committed to facilitating cost-efficient, high-value healthcare delivery. The acquisition of Kaufman Hall in 2024 expanded its capacity to provide advisory services aimed at financial and operational excellence across healthcare organizations. Headquartered in Irving, Texas, Vizient is well-positioned to support providers nationwide.

Coral


Coral stands out as a technology-enabled service provider focused on pharmacy and procurement optimization. Its mission revolves around making specialty care more accessible, efficient, and equitable. By integrating pharmacy cost management technology and value-based contracting, Coral supports infusion centers and community care organizations, driving advancements in the field of specialty care.

Looking Ahead



As Provista and Coral embark on this partnership, the healthcare landscape is likely to see a transformation in the way community infusion centers operate. Through innovative technology and strategic aggregation, they aim to enhance value, ensure optimal resource utilization, and ultimately improve patient outcomes. The collaboration showcases a forward-thinking approach to healthcare cost management, which could set a new benchmark for service delivery in the industry.

With the combined strengths of Provista and Coral, the future of infusion services appears bright, offering independent providers the tools needed to navigate the complexities of modern healthcare procurement effectively.

Topics Health)

【About Using Articles】

You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.

【About Links】

Links are free to use.